SAN ANTONIO--(BUSINESS WIRE)--Nov 6, 2023--. bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for ...
News
- bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales | News
- 22nd Century: Q3 Earnings Snapshot - San Antonio Express-News
The plant biotechnology company posted revenue of $17.8 million in the period, missing Street forecasts. ... San Antonio Police Officer Arieh DeLeon, ...
- Ribometrix Announces Lead Program Target and Presentation of Preclinical Data ... - Business Wire
Additional preclinical data in other indications will be presented at upcoming medical conferences, including the San Antonio Breast Cancer Symposium ...
- bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales - BioSpace
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, ...
- BioCryst pays $5M upfront in licensing deal for vision-loss treatment
A biotechnology company in Research Triangle Park has landed a licensing ... San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa ...